{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:10:01Z","timestamp":1793729401960,"version":"4.6.1"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-026-00685-y","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:02:15Z","timestamp":1772092935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acute rheumatic fever and rheumatic heart disease"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3961-2760","authenticated-orcid":false,"given":"Liesl","family":"Z\u00fchlke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4963-355X","authenticated-orcid":false,"given":"Andrea","family":"Beaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8052-5517","authenticated-orcid":false,"given":"Anu","family":"Gomanju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman Kirshna","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8688-506X","authenticated-orcid":false,"given":"James","family":"Marangou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neema","family":"Minja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-637X","authenticated-orcid":false,"given":"Nicole J.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmy","family":"Okello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-3481","authenticated-orcid":false,"given":"Jafesi","family":"Pulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-818X","authenticated-orcid":false,"given":"Joselyn","family":"Rwebembera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6341-9595","authenticated-orcid":false,"given":"David","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Yilgwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"685_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-007038","volume":"6","author":"J Oliver","year":"2021","unstructured":"Oliver, J. et al. Preceding group A streptococcus skin and throat infections are individually associated with acute rheumatic fever: evidence from New Zealand. BMJ Glob. Health 6, e007038 (2021).","journal-title":"BMJ Glob. Health"},{"key":"685_CR2","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","volume":"131","author":"MH Gewitz","year":"2015","unstructured":"Gewitz, M. H. et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 131, 1806\u20131818 (2015).","journal-title":"Circulation"},{"key":"685_CR3","doi-asserted-by":"publisher","first-page":"e1423","DOI":"10.1016\/S2214-109X(21)00288-6","volume":"9","author":"E Okello","year":"2021","unstructured":"Okello, E. et al. Incidence of acute rheumatic fever in northern and western Uganda: a prospective, population-based study. Lancet Glob. Health 9, e1423\u2013e1430 (2021).","journal-title":"Lancet Glob. Health"},{"key":"685_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.84","volume":"2","author":"JR Carapetis","year":"2016","unstructured":"Carapetis, J. R. et al. Acute rheumatic fever and rheumatic heart disease. Nat. Rev. Dis. Primers 2, 15084 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"685_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/eurheartj\/ehu449","volume":"36","author":"L Z\u00fchlke","year":"2015","unstructured":"Z\u00fchlke, L. et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the global rheumatic heart disease registry (the REMEDY study). Eur. Heart J. 36, 1115\u20131122a (2015).","journal-title":"Eur. Heart J."},{"key":"685_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024769","author":"L Z\u00fchlke","year":"2016","unstructured":"Z\u00fchlke, L. et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low and middle income countries: 2-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY study). Circulation https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024769 (2016).","journal-title":"Circulation"},{"key":"685_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00940-9","author":"J Rwebembera","year":"2023","unstructured":"Rwebembera, J. et al. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease. Nat. Rev. Cardiol. https:\/\/doi.org\/10.1038\/s41569-023-00940-9 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"685_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa2102074","volume":"386","author":"A Beaton","year":"2022","unstructured":"Beaton, A. et al. Secondary antibiotic prophylaxis for latent rheumatic heart disease. N. Engl. J. Med. 386, 230\u2013240 (2022).","journal-title":"N. Engl. J. Med."},{"key":"685_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-022-09345-1","volume":"19","author":"MT Salie","year":"2022","unstructured":"Salie, M. T. et al. Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases. Clin. Proteom. 19, 7 (2022).","journal-title":"Clin. Proteom."},{"key":"685_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/jimaging11040097","volume":"11","author":"L Mugambi","year":"2025","unstructured":"Mugambi, L., Wa Maina, C. & Z\u00fchlke, L. Self-supervised multi-task learning for the detection and classification of RHD-induced valvular pathology. J. Imaging 11, 97 (2025).","journal-title":"J. Imaging"},{"key":"685_CR11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1055\/s-0043-1774812","volume":"14","author":"SR de Loizaga","year":"2023","unstructured":"de Loizaga, S. R. et al. Development and user testing of a dynamic tool for rheumatic heart disease management. Appl. Clin. Inf. 14, 866\u2013877 (2023).","journal-title":"Appl. Clin. Inf."},{"key":"685_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1001\/jama.2024.8258","volume":"332","author":"G Karthikeyan","year":"2024","unstructured":"Karthikeyan, G. et al. Mortality and morbidity in adults with rheumatic heart disease. JAMA 332, 133\u2013140 (2024).","journal-title":"JAMA"},{"key":"685_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4269\/ajtmh.22-0514","volume":"108","author":"AY Chang","year":"2023","unstructured":"Chang, A. Y. et al. What we lost in the fire: endemic tropical heart diseases in the time of COVID-19. Am. J. Trop. Med. Hyg. 108, 462\u2013464 (2023).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"685_CR14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2025-071260","author":"AL Coria","year":"2025","unstructured":"Coria, A. L., Wahl, B., Thacker, N., Vreeman, R. & Z\u00fchlke, L. USAID\u2019s role in saving children\u2019s lives: past legacy and future directions. Pediatrics https:\/\/doi.org\/10.1542\/peds.2025-071260 (2025).","journal-title":"Pediatrics"},{"key":"685_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/CIRCULATIONAHA.113.001477","volume":"128","author":"JG Lawrence","year":"2013","unstructured":"Lawrence, J. G., Carapetis, J. R., Griffiths, K., Edwards, K. & Condon, J. R. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation 128, 492\u2013501 (2013).","journal-title":"Circulation"},{"key":"685_CR16","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1136\/hrt.2007.141309","volume":"94","author":"KB Tibazarwa","year":"2008","unstructured":"Tibazarwa, K. B., Volmink, J. A. & Mayosi, B. M. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 94, 1534\u20131540 (2008).","journal-title":"Heart"},{"key":"685_CR17","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1161\/CIRCULATIONAHA.112.092312","volume":"125","author":"A Beaton","year":"2012","unstructured":"Beaton, A. et al. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation 125, 3127\u20133132 (2012).","journal-title":"Circulation"},{"key":"685_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016851","volume":"9","author":"JM Katzenellenbogen","year":"2020","unstructured":"Katzenellenbogen, J. M. et al. Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change. J. Am. Heart Assoc. 9, e016851 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"685_CR19","unstructured":"Institute for Health Metrics and Evaluation. GBD Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021): Results. IHME https:\/\/vizhub.healthdata.org\/gbd-results\/ (2021)."},{"key":"685_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8834443","volume":"2023","author":"G Mebrahtom","year":"2023","unstructured":"Mebrahtom, G., Hailay, A., Aberhe, W., Zereabruk, K. & Haile, T. Rheumatic heart disease in East Africa: a systematic review and meta-analysis. Int. J. Rheumatol. 2023, 8834443 (2023).","journal-title":"Int. J. Rheumatol."},{"key":"685_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ihj.2020.09.011","volume":"72","author":"PC Negi","year":"2020","unstructured":"Negi, P. C. et al. Gender differences in the epidemiology of rheumatic fever\/rheumatic heart disease (RF\/RHD) patient population of hill state of northern India; 9 years prospective hospital based, HP-RHD registry. Indian Heart J. 72, 552\u2013556 (2020).","journal-title":"Indian Heart J."},{"key":"685_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijcard.2022.04.010","volume":"358","author":"P Lamichhane","year":"2022","unstructured":"Lamichhane, P. et al. Prevalence of rheumatic heart disease in South Asia: a systematic review and meta-analysis. Int. J. Cardiol. 358, 110\u2013119 (2022).","journal-title":"Int. J. Cardiol."},{"key":"685_CR23","unstructured":"WHO. Rheumatic heart disease and rheumatic fever programmes in the WHO African Brazzaville: WHO African Region WHO https:\/\/www.afro.who.int\/publications\/rheumatic-heart-disease-and-rheumatic-fever-programmes-who-african-region-review (2025)."},{"key":"685_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMoa1603693","volume":"377","author":"DA Watkins","year":"2017","unstructured":"Watkins, D. A. et al. Global, regional, and national burden of rheumatic heart disease, 1990\u20132015. N. Engl. J. Med. 377, 713\u2013722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"685_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa065085","volume":"357","author":"E Marijon","year":"2007","unstructured":"Marijon, E. et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357, 470\u2013476 (2007).","journal-title":"N. Engl. J. Med."},{"key":"685_CR26","doi-asserted-by":"publisher","first-page":"e957","DOI":"10.1016\/S2214-109X(21)00199-6","volume":"9","author":"MM Coates","year":"2021","unstructured":"Coates, M. M. et al. An investment case for the prevention and management of rheumatic heart disease in the African Union 2021\u201330: a modelling study. Lancet Glob. Health 9, e957\u2013e966 (2021).","journal-title":"Lancet Glob. Health"},{"key":"685_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01526-9","volume":"18","author":"AD Lopez","year":"2020","unstructured":"Lopez, A. D., McLaughlin, D. & Richards, N. Reducing ignorance about who dies of what: research and innovation to strengthen CRVS systems. BMC Med. 18, 58 (2020).","journal-title":"BMC Med."},{"key":"685_CR28","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1016\/j.hlc.2019.08.020","volume":"29","author":"JA Fitz-Gerald","year":"2020","unstructured":"Fitz-Gerald, J. A. et al. A validation study: how predictive is a diagnostic coding algorithm at identifying rheumatic heart disease in Western Australian hospital data? Heart Lung Circulation 29, e194\u2013e199 (2020).","journal-title":"Heart Lung Circulation"},{"key":"685_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004033","volume":"9","author":"T Parks","year":"2015","unstructured":"Parks, T. et al. Rheumatic heart disease\u2014attributable mortality at ages 5\u201369 years in Fiji: a five-year, national, population-based record-linkage cohort study. PLoS Negl. Trop. Dis. 9, e0004033 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"685_CR30","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCULATIONAHA.116.024769","volume":"134","author":"L Z\u00fchlke","year":"2016","unstructured":"Z\u00fchlke, L. et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low-and middle-income countries: two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY study). Circulation 134, 1456\u20131466 (2016).","journal-title":"Circulation"},{"key":"685_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-070629","volume":"13","author":"T Parks","year":"2023","unstructured":"Parks, T. et al. Population-based assessment of cardiovascular complications of rheumatic heart disease in Fiji: a record-linkage analysis. BMJ Open 13, e070629 (2023).","journal-title":"BMJ Open"},{"key":"685_CR32","volume":"26","author":"MG Baker","year":"2022","unstructured":"Baker, M. G. et al. Risk factors for acute rheumatic fever: a case-control study. Lancet Reg. Health West. Pac. 26, 100508 (2022).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"685_CR33","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.3390\/ijerph16224515","volume":"16","author":"MG Baker","year":"2019","unstructured":"Baker, M. G. et al. Risk factors for acute rheumatic fever: literature review and protocol for a case-control study in New Zealand. Int. J. Environ. Res. Public Health 16, 4515 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"685_CR34","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/CIRCULATIONAHA.108.792135","volume":"119","author":"PA Bryant","year":"2009","unstructured":"Bryant, P. A., Robins-Browne, R., Carapetis, J. R. & Curtis, N. Some of the people, some of the time susceptibility to acute rheumatic fever. Circulation 119, 742\u2013753 (2009).","journal-title":"Circulation"},{"key":"685_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41569-019-0258-2","volume":"17","author":"B Muhamed","year":"2020","unstructured":"Muhamed, B., Parks, T. & Sliwa, K. Genetics of rheumatic fever and rheumatic heart disease. Nat. Rev. Cardiol. 17, 145\u2013154 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"685_CR36","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/infdis\/jix497","volume":"216","author":"LA Gray","year":"2017","unstructured":"Gray, L. A. et al. Genome-wide analysis of genetic risk factors for rheumatic heart disease in Aboriginal Australians provides support for pathogenic molecular mimicry. J. Infect. Dis. 216, 1460\u20131470 (2017).","journal-title":"J. Infect. Dis."},{"key":"685_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14946","volume":"8","author":"T Parks","year":"2017","unstructured":"Parks, T. et al. Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania. Nat. Commun. 8, 14946 (2017).","journal-title":"Nat. Commun."},{"key":"685_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65855-8","volume":"10","author":"K Auckland","year":"2020","unstructured":"Auckland, K. et al. The human leukocyte antigen locus and rheumatic heart disease susceptibility in South Asians and Europeans. Sci. Rep. 10, 9004 (2020).","journal-title":"Sci. Rep."},{"key":"685_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.121.003641","volume":"16","author":"T Machipisa","year":"2023","unstructured":"Machipisa, T. et al. Rationale, design, and the baseline characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study. Circ. Genom. Precis. Med. 16, e003641 (2023).","journal-title":"Circ. Genom. Precis. Med."},{"key":"685_CR40","first-page":"483","volume":"67","author":"JI Levine","year":"1966","unstructured":"Levine, J. I., Chapman, S. S., Guerra, V., Cooper, J. & Krause, R. M. Studies on the transmission within families of Group A hemolytic streptococci. J. Lab. Clin. Med. 67, 483\u2013494 (1966).","journal-title":"J. Lab. Clin. Med."},{"key":"685_CR41","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1542\/peds.2006-3368","volume":"120","author":"MH Danchin","year":"2007","unstructured":"Danchin, M. H. et al. Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia. Pediatrics 120, 950\u2013957 (2007).","journal-title":"Pediatrics"},{"key":"685_CR42","first-page":"101","volume":"51","author":"J Spitzer","year":"2001","unstructured":"Spitzer, J., Hennessy, E. & Neville, L. High group A streptococcal carriage in the Orthodox Jewish community of North Hackney. Br. J. Gen. Pract. 51, 101\u2013105 (2001).","journal-title":"Br. J. Gen. Pract."},{"key":"685_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006577","volume":"12","author":"PM Coffey","year":"2018","unstructured":"Coffey, P. M., Ralph, A. P. & Krause, V. L. The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: a systematic review. PLoS Negl. Trop. Dis. 12, e0006577 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"685_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14629","author":"S Gupta","year":"2025","unstructured":"Gupta, S., Thornley, S., Morris, A., Sundborn, G. & Grant, C. Is scabies the key to rheumatic heart disease prevention? A systematic review of the evidence. Australas. J. Dermatol. https:\/\/doi.org\/10.1111\/ajd.14629 (2025).","journal-title":"Australas. J. Dermatol."},{"key":"685_CR45","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/cid\/ciab180","volume":"73","author":"N Lorenz","year":"2021","unstructured":"Lorenz, N. et al. Serological profiling of group A Streptococcus infections in acute rheumatic fever. Clin. Infect. Dis. 73, 2322\u20132325 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"685_CR46","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S2666-5247(24)00046-6","volume":"5","author":"EP Armitage","year":"2024","unstructured":"Armitage, E. P. et al. Streptococcus pyogenes carriage and infection within households in The Gambia: a longitudinal cohort study. Lancet Microbe 5, 679\u2013688 (2024).","journal-title":"Lancet Microbe"},{"key":"685_CR47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1086\/506938","volume":"43","author":"MI McDonald","year":"2006","unstructured":"McDonald, M. I. et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin. Infect. Dis. 43, 683\u2013689 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"685_CR48","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/BOR.0b013e32835461d3","volume":"24","author":"MW Cunningham","year":"2012","unstructured":"Cunningham, M. W. Streptococcus and rheumatic fever. Curr. Opin. Rheumatol. 24, 408\u2013416 (2012).","journal-title":"Curr. Opin. Rheumatol."},{"key":"685_CR49","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.4049\/jimmunol.176.9.5662","volume":"176","author":"KC Fa\u00e9","year":"2006","unstructured":"Fa\u00e9, K. C. et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J. Immunol. 176, 5662\u20135670 (2006).","journal-title":"J. Immunol."},{"key":"685_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1172\/JCI7132","volume":"106","author":"JE Galvin","year":"2000","unstructured":"Galvin, J. E., Hemric, M. E., Ward, K. & Cunningham, M. W. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J. Clin. Invest. 106, 217\u2013224 (2000).","journal-title":"J. Clin. Invest."},{"key":"685_CR51","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/08916934.2016.1217999","volume":"49","author":"D Gorton","year":"2016","unstructured":"Gorton, D. et al. Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease. Autoimmunity 49, 563\u2013570 (2016).","journal-title":"Autoimmunity"},{"key":"685_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01272-0","volume":"10","author":"T Parks","year":"2025","unstructured":"Parks, T., Cunningham, M. W. & Saul, A. No compelling evidence that vaccination with Streptococcus pyogenes group A carbohydrate elicits cross-reactive rheumatic fever autoantibodies. npj Vaccines 10, 224 (2025).","journal-title":"npj Vaccines"},{"key":"685_CR53","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1128\/IAI.01514-08","volume":"77","author":"D Gorton","year":"2009","unstructured":"Gorton, D., Govan, B., Olive, C. & Ketheesan, N. B- and T-cell responses in Group A Streptococcus M-protein- or peptide-induced experimental carditis. Infect. Immun. 77, 2177\u20132183 (2009).","journal-title":"Infect. Immun."},{"key":"685_CR54","doi-asserted-by":"publisher","first-page":"7132","DOI":"10.1128\/IAI.68.12.7132-7136.2000","volume":"68","author":"KF Jones","year":"2000","unstructured":"Jones, K. F., Whitehead, S. S., Cunningham, M. W. & Fischetti, V. A. Reactivity of rheumatic fever and scarlet fever patients\u2019 sera with Group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study. Infect. Immun. 68, 7132\u20137136 (2000).","journal-title":"Infect. Immun."},{"key":"685_CR55","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2310\/JIM.0000000000000023","volume":"62","author":"HD Bas","year":"2014","unstructured":"Bas, H. D. et al. A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease. J. Investig. Med. 62, 78 (2014).","journal-title":"J. Investig. Med."},{"key":"685_CR56","doi-asserted-by":"publisher","first-page":"110558","DOI":"10.1016\/j.isci.2024.110558","volume":"27","author":"N Lorenz","year":"2024","unstructured":"Lorenz, N. et al. An acute rheumatic fever immune signature comprising inflammatory markers, IgG3 and Streptococcus pyogenes specific antibodies. iScience 27, 110558 (2024).","journal-title":"iScience"},{"key":"685_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s004310050545","volume":"156","author":"O Ye\u011fin","year":"1997","unstructured":"Ye\u011fin, O., Co\u015fkun, M. & Ertu\u011f, H. Cytokines in acute rheumatic fever. Eur. J. Pediatr. 156, 25\u201329 (1997).","journal-title":"Eur. J. Pediatr."},{"key":"685_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/imcb.12298","volume":"98","author":"AW Chung","year":"2020","unstructured":"Chung, A. W. et al. Systems immunology reveals a linked IgG3-C4 response in patients with acute rheumatic fever. Immunol. Cell Biol. 98, 12\u201321 (2020).","journal-title":"Immunol. Cell Biol."},{"key":"685_CR59","volume":"59","author":"G Afshan","year":"2025","unstructured":"Afshan, G. et al. Circulating prothymosin alpha and immunoglobulin G3 in acute rheumatic fever and rheumatic heart disease: a case-control study. Am. Heart J. 59, 100630 (2025).","journal-title":"Am. Heart J."},{"key":"685_CR60","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1128\/jcm.34.4.953-958.1996","volume":"34","author":"B Beall","year":"1996","unstructured":"Beall, B., Facklam, R. & Thompson, T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34, 953\u2013958 (1996).","journal-title":"J. Clin. Microbiol."},{"key":"685_CR61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jinf.2006.03.006","volume":"53","author":"ST Shulman","year":"2006","unstructured":"Shulman, S. T., Stollerman, G., Beall, B., Dale, J. B. & Tanz, R. R. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. J. Infect. 53, 216 (2006).","journal-title":"J. Infect."},{"key":"685_CR62","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00469-22","volume":"8","author":"SY Bah","year":"2022","unstructured":"Bah, S. Y. et al. Genomic characterization of skin and soft tissue Streptococcus pyogenes isolates from a low-income and a high-income setting. mSphere 8, e0046922 (2022).","journal-title":"mSphere"},{"key":"685_CR63","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00421-19","volume":"4","author":"DD Barth","year":"2019","unstructured":"Barth, D. D. et al. Molecular epidemiology of noninvasive and invasive Group A streptococcal infections in Cape Town. mSphere 4, e00421-19 (2019).","journal-title":"mSphere"},{"key":"685_CR64","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/infdis\/jiaf252","volume":"232","author":"G de Crombrugghe","year":"2025","unstructured":"de Crombrugghe, G. et al. Household molecular epidemiology of Streptococcus pyogenes carriage and infection in The Gambia. J. Infect. Dis. 232, 550\u2013559 (2025).","journal-title":"J. Infect. Dis."},{"key":"685_CR65","first-page":"100964","volume":"42","author":"JA Lacey","year":"2023","unstructured":"Lacey, J. A. et al. A worldwide population of Streptococcus pyogenes strains circulating among school-aged children in Auckland, New Zealand: a genomic epidemiology analysis. Lancet Reg. Health West. Pac. 42, 100964 (2023).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"685_CR66","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/S2666-5247(23)00318-X","volume":"5","author":"PR Smeesters","year":"2024","unstructured":"Smeesters, P. R. et al. Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic review. Lancet Microbe 5, e181\u2013e193 (2024).","journal-title":"Lancet Microbe"},{"key":"685_CR67","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1128\/JCM.02129-15","volume":"53","author":"DA Williamson","year":"2015","unstructured":"Williamson, D. A. et al. M-protein analysis of Streptococcus pyogenes isolates associated with acute rheumatic fever in New Zealand. J. Clin. Microbiol. 53, 3618\u20133620 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"685_CR68","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/cid\/ciz425","volume":"70","author":"G de Crombrugghe","year":"2020","unstructured":"de Crombrugghe, G. et al. The limitations of the rheumatogenic concept for group A Streptococcus: systematic review and genetic analysis. Clin. Infect. Dis. 70, 1453\u20131460 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"685_CR69","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJM196409242711301","volume":"271","author":"MH Kaplan","year":"1964","unstructured":"Kaplan, M. H., Bolande, R., Rakita, L. & Blair, J. Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever \u2014 association with cardiac failure. N. Engl. J. Med. 271, 637\u2013645 (1964).","journal-title":"N. Engl. J. Med."},{"key":"685_CR70","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/infdis\/jiac043","volume":"226","author":"AL Whitcombe","year":"2022","unstructured":"Whitcombe, A. L. et al. Increased breadth of group A Streptococcus antibody responses in children with acute rheumatic fever compared to precursor pharyngitis and skin infections. J. Infect. Dis. 226, 167\u2013176 (2022).","journal-title":"J. Infect. Dis."},{"key":"685_CR71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.it.2019.01.005","volume":"40","author":"T Damelang","year":"2019","unstructured":"Damelang, T., Rogerson, S. J., Kent, S. J. & Chung, A. W. Role of IgG3 in infectious diseases. Trends Immunol. 40, 197\u2013211 (2019).","journal-title":"Trends Immunol."},{"key":"685_CR72","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1086\/656214","volume":"202","author":"NMJ Ellis","year":"2010","unstructured":"Ellis, N. M. J. et al. Priming the immune system for heart disease: a perspective on group A streptococci. J. Infect. Dis. 202, 1059\u20131067 (2010).","journal-title":"J. Infect. Dis."},{"key":"685_CR73","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/intimm\/dxn004","volume":"20","author":"TB Martins","year":"2008","unstructured":"Martins, T. B. et al. Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever. Int. Immunol. 20, 445\u2013452 (2008).","journal-title":"Int. Immunol."},{"key":"685_CR74","doi-asserted-by":"publisher","first-page":"702877","DOI":"10.3389\/fimmu.2021.702877","volume":"12","author":"R McGregor","year":"2021","unstructured":"McGregor, R. et al. Mapping autoantibodies in children with acute rheumatic fever. Front. Immunol. 12, 702877 (2021).","journal-title":"Front. Immunol."},{"key":"685_CR75","doi-asserted-by":"publisher","first-page":"ftab033","DOI":"10.1093\/femspd\/ftab033","volume":"79","author":"DH Pilapitiya","year":"2021","unstructured":"Pilapitiya, D. H. et al. Antibody responses to collagen peptides and streptococcal collagen-like 1 proteins in acute rheumatic fever patients. Pathog. Dis. 79, ftab033 (2021).","journal-title":"Pathog. Dis."},{"key":"685_CR76","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1046\/j.1365-2958.2003.03352.x","volume":"47","author":"K Dinkla","year":"2003","unstructured":"Dinkla, K. et al. Streptococcus pyogenes recruits collagen via surface-bound fibronectin: a novel colonization and immune evasion mechanism. Mol. Microbiol. 47, 861\u2013869 (2003).","journal-title":"Mol. Microbiol."},{"key":"685_CR77","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/0974-2069.99621","volume":"5","author":"R Tandon","year":"2012","unstructured":"Tandon, R. Rheumatic fever pathogenesis: approach in research needs change. Ann. Pediatr. Cardiol. 5, 169\u2013174 (2012).","journal-title":"Ann. Pediatr. Cardiol."},{"key":"685_CR78","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCULATIONAHA.121.057301","volume":"145","author":"LSA Passos","year":"2022","unstructured":"Passos, L. S. A. et al. Prothymosin alpha: a novel contributor to estradiol receptor alpha-mediated CD8+ T-cell pathogenic responses and recognition of type 1 collagen in rheumatic heart valve disease. Circulation 145, 531\u2013548 (2022).","journal-title":"Circulation"},{"key":"685_CR79","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.196619","author":"R McGregor","year":"2025","unstructured":"McGregor, R. et al. PhIP-Seq uncovers marked heterogeneity in acute rheumatic fever autoantibodies. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.196619 (2025).","journal-title":"JCI Insight"},{"key":"685_CR80","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s12026-023-09362-8","volume":"7","author":"LH Carlton","year":"2023","unstructured":"Carlton, L. H., McGregor, R. & Moreland, N. J. Human antibody profiling technologies for autoimmune disease. AImmunol. Res. 7, 516\u2013527 (2023).","journal-title":"Immunol. Res."},{"key":"685_CR81","doi-asserted-by":"publisher","first-page":"103209","DOI":"10.1016\/j.autrev.2022.103209","volume":"21","author":"FM Middleton","year":"2022","unstructured":"Middleton, F. M., McGregor, R., Webb, R. H., Wilson, N. J. & Moreland, N. J. Cytokine imbalance in acute rheumatic fever and rheumatic heart disease: mechanisms and therapeutic implications. Autoimmun. Rev. 21, 103209 (2022).","journal-title":"Autoimmun. Rev."},{"key":"685_CR82","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.carpath.2015.07.006","volume":"24","author":"Y Wen","year":"2015","unstructured":"Wen, Y., Zeng, Z., Gui, C., Li, L. & Li, W. Changes in the expression of Th17 cell-associated cytokines in the development of rheumatic heart disease. Cardiovasc. Pathol. 24, 382\u2013387 (2015).","journal-title":"Cardiovasc. Pathol."},{"key":"685_CR83","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1161\/CIRCULATIONAHA.118.033891","volume":"138","author":"ML Kim","year":"2018","unstructured":"Kim, M. L. et al. Dysregulated IL-1\u03b2-GM-CSF axis in acute rheumatic fever that is limited by hydroxychloroquine. Circulation 138, 2648\u20132661 (2018).","journal-title":"Circulation"},{"key":"685_CR84","doi-asserted-by":"publisher","unstructured":"Middleton, F. A. M. et al. Perturbation of the T cell compartment underlies rheumatic fever pathogenesis. Preprint at https:\/\/doi.org\/10.2139\/ssrn.5145933 (2025).","DOI":"10.2139\/ssrn.5145933"},{"key":"685_CR85","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10753-013-9606-2","volume":"36","author":"KC Fa\u00e9","year":"2013","unstructured":"Fa\u00e9, K. C. et al. CXCL9\/Mig mediates T cells recruitment to valvular tissue lesions of chronic rheumatic heart disease patients. Inflammation 36, 800\u2013811 (2013).","journal-title":"Inflammation"},{"key":"685_CR86","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/318076","volume":"183","author":"S Roberts","year":"2001","unstructured":"Roberts, S., Kosanke, S., Duran, C. M. & Cunningham, M. W. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J. Infect. Dis. 183, 507\u2013511 (2001).","journal-title":"J. Infect. Dis."},{"key":"685_CR87","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1365-2559.1995.tb00310.x","volume":"27","author":"WJ Fraser","year":"1995","unstructured":"Fraser, W. J., Haffejee, Z. & Cooper, K. Rheumatic Aschoff nodules revisited: an immunohistological reappraisal of the cellular component. Histopathology 27, 457\u2013461 (1995).","journal-title":"Histopathology"},{"key":"685_CR88","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0002-9440(10)63415-3","volume":"165","author":"L Guilherme","year":"2004","unstructured":"Guilherme, L. et al. Rheumatic heart disease proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am. J. Pathol. 165, 1583\u20131591 (2004).","journal-title":"Am. J. Pathol."},{"key":"685_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203756","volume":"13","author":"M Shiba","year":"2018","unstructured":"Shiba, M. et al. Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease. PLoS ONE 13, e0203756 (2018).","journal-title":"PLoS ONE"},{"key":"685_CR90","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.120.050955","volume":"142","author":"G Karthikeyan","year":"2020","unstructured":"Karthikeyan, G., Fung, E. & Foo, R. S. Y. Alternative hypothesis to explain disease progression in rheumatic heart disease. Circulation 142, 2091\u20132094 (2020).","journal-title":"Circulation"},{"key":"685_CR91","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053720","volume":"11","author":"AP Ralph","year":"2021","unstructured":"Ralph, A. P. et al. Searching for a technology-driven acute rheumatic fever test: the START study protocol. BMJ Open 11, e053720 (2021).","journal-title":"BMJ Open"},{"key":"685_CR92","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062624","volume":"153","author":"J Pulle","year":"2024","unstructured":"Pulle, J. et al. Specificity of the modified Jones Criteria. Pediatrics 153, e2023062624 (2024).","journal-title":"Pediatrics"},{"key":"685_CR93","doi-asserted-by":"publisher","first-page":"113954","DOI":"10.1016\/j.jpeds.2024.113954","volume":"268","author":"S Ali","year":"2024","unstructured":"Ali, S., Beaton, A., Ndagire, E. & Alhag, L. Silent acute rheumatic fever unmasked by using handheld echocardiography for febrile children presenting in a rheumatic heart disease-endemic area. J. Pediatr. 268, 113954 (2024).","journal-title":"J. Pediatr."},{"key":"685_CR94","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050478","volume":"12","author":"E Ndagire","year":"2022","unstructured":"Ndagire, E. et al. Modelling study of the ability to diagnose acute rheumatic fever at different levels of the Ugandan healthcare system. BMJ Open 12, e050478 (2022).","journal-title":"BMJ Open"},{"key":"685_CR95","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-099827","volume":"15","author":"R Peiris","year":"2025","unstructured":"Peiris, R. et al. Diverse diagnostic and management approaches for acute rheumatic fever in Australia and New Zealand: findings of a prospective clinical study. BMJ Open 15, e099827 (2025).","journal-title":"BMJ Open"},{"key":"685_CR96","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto, C. M. et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143, e72\u2013e227 (2021).","journal-title":"Circulation"},{"key":"685_CR97","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrcardio.2012.7","volume":"9","author":"B Rem\u00e9nyi","year":"2012","unstructured":"Rem\u00e9nyi, B. et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease\u2014an evidence-based guideline. Nat. Rev. Cardiol. 9, 297\u2013309 (2012).","journal-title":"Nat. Rev. Cardiol."},{"key":"685_CR98","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeab035","volume":"1","author":"I Stacey","year":"2021","unstructured":"Stacey, I. et al. Long-term outcomes following rheumatic heart disease diagnosis in Australia. Eur. Heart J. Open 1, oeab035 (2021).","journal-title":"Eur. Heart J. Open"},{"key":"685_CR99","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/heartjnl-2021-320356","volume":"108","author":"M Zimmerman","year":"2022","unstructured":"Zimmerman, M. et al. Clinical outcomes of children with rheumatic heart disease. Heart 108, 633\u2013638 (2022).","journal-title":"Heart"},{"key":"685_CR100","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1056\/NEJMe1705840","volume":"377","author":"E Marijon","year":"2017","unstructured":"Marijon, E., Celermajer, D. S. & Jouven, X. Rheumatic heart disease - an iceberg in tropical waters. N. Engl. J. Med. 377, 780\u2013781 (2017).","journal-title":"N. Engl. J. Med."},{"key":"685_CR101","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.gheart.2013.08.008","volume":"8","author":"LJ Zuhlke","year":"2013","unstructured":"Zuhlke, L. J. & Steer, A. C. Estimates of the global burden of rheumatic heart disease. Glob. Heart 8, 189\u2013195 (2013).","journal-title":"Glob. Heart"},{"key":"685_CR102","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gheart.2016.10.028","volume":"12","author":"LJ Z\u00fchlke","year":"2017","unstructured":"Z\u00fchlke, L. J. et al. A comprehensive needs assessment tool for planning RHD control programs in limited resource settings. Glob. Heart 12, 25\u201331 (2017).","journal-title":"Glob. Heart"},{"key":"685_CR103","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5334\/gh.1327","volume":"19","author":"J Marangou","year":"2024","unstructured":"Marangou, J. et al. The echocardiographic diagnosis of rheumatic heart disease: a review of the performance of the World Heart Federation Criteria 2012\u20132023. Glob. Heart 19, 47 (2024).","journal-title":"Glob. Heart"},{"key":"685_CR104","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1161\/CIRCULATIONAHA.113.003495","volume":"129","author":"K Roberts","year":"2014","unstructured":"Roberts, K. et al. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation 129, 1953\u20131961 (2014).","journal-title":"Circulation"},{"key":"685_CR105","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.echo.2015.11.013","volume":"29","author":"BC Clark","year":"2016","unstructured":"Clark, B. C. et al. Using a low-risk population to estimate the specificity of the World Heart Federation Criteria for the diagnosis of rheumatic heart disease. J. Am. Soc. Echocardiogr. 29, 253\u2013258 (2016).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"685_CR106","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ijcard.2017.04.004","volume":"240","author":"D Engelman","year":"2017","unstructured":"Engelman, D. et al. Clinical outcomes for young people with screening-detected and clinically-diagnosed rheumatic heart disease in Fiji. Int. J. Cardiol. 240, 422\u2013427 (2017).","journal-title":"Int. J. Cardiol."},{"key":"685_CR107","unstructured":"WHO. WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease. WHO https:\/\/www.who.int\/publications\/i\/item\/9789240100077 (2024)."},{"key":"685_CR108","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/diagnostics14040392","volume":"14","author":"MG Diniz","year":"2024","unstructured":"Diniz, M. G. et al. Agreement between handheld and standard echocardiography for diagnosis of latent rheumatic heart disease in Brazilian schoolchildren from high-prevalence settings (agreement between screening and standard echo for RHD). Diagnostics 14, 392 (2024).","journal-title":"Diagnostics"},{"key":"685_CR109","unstructured":"WHO. Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases 2nd edn. WHO https:\/\/www.who.int\/publications\/i\/item\/9789240091078 (2024)."},{"key":"685_CR110","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41591-023-02646-4","volume":"30","author":"D Nakagaayi","year":"2024","unstructured":"Nakagaayi, D. et al. A decentralized delivery program for rheumatic heart disease treatment and prevention in Uganda. Nat. Med. 30, 12\u201313 (2024).","journal-title":"Nat. Med."},{"key":"685_CR111","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-083467","volume":"14","author":"B Jones","year":"2024","unstructured":"Jones, B. et al. NEARER SCAN (LENO BESIK) evaluation of a task-sharing echocardiographic active case finding programme for rheumatic heart disease in Australia and Timor-Leste: protocol for a hybrid type II effectiveness-implementation study. BMJ Open 14, e083467 (2024).","journal-title":"BMJ Open"},{"key":"685_CR112","unstructured":"Steer, A. in Oxford Textbook of Rheumatology (eds Richard A. Watts et al.) Ch. 108 (Oxford Univ. Press, 2013)."},{"key":"685_CR113","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012467","volume":"8","author":"MG Baker","year":"2023","unstructured":"Baker, M. G. et al. Research priorities for the primordial prevention of acute rheumatic fever and rheumatic heart disease by modifying the social determinants of health. BMJ Glob. Health 8, e012467 (2023).","journal-title":"BMJ Glob. Health"},{"key":"685_CR114","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012356","volume":"8","author":"J Rwebembera","year":"2023","unstructured":"Rwebembera, J. et al. Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop report. BMJ Glob. Health 8, e012356 (2023).","journal-title":"BMJ Glob. Health"},{"key":"685_CR115","doi-asserted-by":"publisher","first-page":"10215","DOI":"10.3390\/ijerph191610215","volume":"19","author":"AP Ralph","year":"2022","unstructured":"Ralph, A. P. et al. Evaluation of a community-led program for primordial and primary prevention of rheumatic fever in remote Northern Australia. Int. J. Env. Res. Public Health 19, 10215 (2022).","journal-title":"Int. J. Env. Res. Public Health"},{"key":"685_CR116","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1016\/j.vaccine.2022.02.040","volume":"40","author":"E Sparrow","year":"2022","unstructured":"Sparrow, E. et al. WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - key considerations for global use. Vaccine 40, 3506\u20133510 (2022).","journal-title":"Vaccine"},{"key":"685_CR117","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/S2666-5247(20)30240-8","volume":"2","author":"J Osowicki","year":"2021","unstructured":"Osowicki, J. et al. A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study. Lancet Microbe 2, e291\u2013e299 (2021).","journal-title":"Lancet Microbe"},{"key":"685_CR118","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.puhe.2023.12.004","volume":"227","author":"M Bakhit","year":"2024","unstructured":"Bakhit, M. et al. Diagnostic performance of clinical prediction rules to detect group A beta-haemolytic streptococci in people with acute pharyngitis: a systematic review. Public Health 227, 219\u2013227 (2024).","journal-title":"Public Health"},{"key":"685_CR119","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/01.CIR.48.1.9","volume":"48","author":"LW Wannamaker","year":"1973","unstructured":"Wannamaker, L. W. The chain that links the heart to the throat. Circulation 48, 9\u201318 (1973).","journal-title":"Circulation"},{"key":"685_CR120","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0002-9343(54)90219-3","volume":"17","author":"FJ Catanzaro","year":"1954","unstructured":"Catanzaro, F. J. et al. The role of the Streptococcus in the pathogenesis of rheumatic fever. Am. J. Med. 17, 749\u2013756 (1954).","journal-title":"Am. J. Med."},{"key":"685_CR121","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jama.1950.02910370001001","volume":"143","author":"FW Denny","year":"1950","unstructured":"Denny, F. W., Wannamaker, L. W., Brink, W. R., Rammelkamp, C. H. Jr & Custer, E. A. Prevention of rheumatic fever; treatment of the preceding streptococcic infection. J. Am. Med. Assoc. 143, 151\u2013153 (1950).","journal-title":"J. Am. Med. Assoc."},{"key":"685_CR122","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/INF.0b013e3181a282be","volume":"28","author":"D Lennon","year":"2009","unstructured":"Lennon, D., Stewart, J., Farrell, E., Palmer, A. & Mason, H. School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand. Pediatric Infect. Dis. J. 28, 787\u2013794 (2009).","journal-title":"Pediatric Infect. Dis. J."},{"key":"685_CR123","first-page":"47","volume":"115","author":"K Rampersadh","year":"2025","unstructured":"Rampersadh, K., Salie, M., Engel, K., Moodley, C. & Engel, M. Penicillin remains an effective agent against Group A Streptococcus in low-and middle-income countries: a systematic review and meta-analysis of antibiotic resistance and associated genes. South Afr. Med. J. 115, 47\u201354 (2025).","journal-title":"South Afr. Med. J."},{"key":"685_CR124","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/CIRCOUTCOMES.111.000032","volume":"6","author":"J Irlam","year":"2013","unstructured":"Irlam, J., Mayosi, B. M., Engel, M. & Gaziano, T. A. Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis. Circ. Cardiovasc. Qual. Outcomes 6, 343\u2013351 (2013).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"685_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136789","volume":"10","author":"AC Bowen","year":"2015","unstructured":"Bowen, A. C. et al. The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma. PLoS ONE 10, e0136789 (2015).","journal-title":"PLoS ONE"},{"key":"685_CR126","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/S0140-6736(14)60841-2","volume":"384","author":"AC Bowen","year":"2014","unstructured":"Bowen, A. C. et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet 384, 2132\u20132140 (2014).","journal-title":"Lancet"},{"key":"685_CR127","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/jpc.13851","volume":"54","author":"S Thornley","year":"2018","unstructured":"Thornley, S. et al. Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children. J. Paediatr. Child Health 54, 625\u2013632 (2018).","journal-title":"J. Paediatr. Child Health"},{"key":"685_CR128","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/INF.0000000000001558","volume":"36","author":"L O\u2019Sullivan","year":"2017","unstructured":"O\u2019Sullivan, L., Moreland, N. J., Webb, R. H., Upton, A. & Wilson, N. J. Acute rheumatic fever after Group A Streptococcus pyoderma and Group G Streptococcus pharyngitis. Pediatr. Infect. Dis. J. 36, 692\u2013694 (2017).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"685_CR129","doi-asserted-by":"publisher","first-page":"102793","DOI":"10.1016\/j.eclinm.2024.102793","volume":"77","author":"HMM Thomas","year":"2024","unstructured":"Thomas, H. M. M. et al. Multi-methods process evaluation of the SToP (See, Treat, Prevent) trial: a cluster randomised, stepped wedge trial to support healthy skin. eClinicalMedicine 77, 102793 (2024).","journal-title":"eClinicalMedicine"},{"key":"685_CR130","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/01.CIR.45.3.543","volume":"45","author":"DG Tompkins","year":"1972","unstructured":"Tompkins, D. G., Boxerbaum, B. & Liebman, J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 45, 543\u2013551 (1972).","journal-title":"Circulation"},{"key":"685_CR131","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/01.CIR.4.6.836","volume":"4","author":"EF Bland","year":"1951","unstructured":"Bland, E. F. & Jones, D. Rheumatic fever and rheumatic heart disease: a twenty year report on 1000 patients followed since childhood. Circulation 4, 836\u2013843 (1951).","journal-title":"Circulation"},{"key":"685_CR132","first-page":"CD015779","volume":"9","author":"JJ Bray","year":"2024","unstructured":"Bray, J. J. et al. Long-term antibiotic prophylaxis for prevention of rheumatic fever recurrence and progression to rheumatic heart disease. Cochrane Database Syst. Rev. 9, CD015779 (2024).","journal-title":"Cochrane Database Syst. Rev."},{"key":"685_CR133","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05693545 (2024)."},{"key":"685_CR134","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0022-3476(86)81009-5","volume":"108","author":"H-C Lue","year":"1986","unstructured":"Lue, H.-C. et al. Rheumatic fever recurrences: controlled study of 3-week versus 4-week benzathine penicillin prevention programs. J. Pediatr. 108, 299\u2013304 (1986).","journal-title":"J. Pediatr."},{"key":"685_CR135","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/jac\/dkac231","volume":"77","author":"J Kado","year":"2022","unstructured":"Kado, J. et al. Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia. J. Antimicrob. Chemother. 77, 2679\u20132682 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"685_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1403131","volume":"11","author":"KM Ali Sulafa","year":"2024","unstructured":"Ali Sulafa, K. M., Karrar, Z. A., Elkurdufani, N. & Ibrahim, N. Sudan\u2019s rheumatic fever and rheumatic heart disease guidelines: a simplified approach in an endemic country. Front. Cardiovasc. Med. 11, 1403131 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"685_CR137","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.aller.2012.12.007","volume":"42","author":"A Kaya","year":"2014","unstructured":"Kaya, A. et al. Confirmed penicillin allergy among patients receiving benzathine penicillin prophylaxis for acute rheumatic fever. Allergol. Immunopathol. 42, 289\u2013292 (2014).","journal-title":"Allergol. Immunopathol."},{"key":"685_CR138","doi-asserted-by":"publisher","first-page":"165","DOI":"10.21037\/cdt.2018.12.09","volume":"9","author":"S Ali","year":"2019","unstructured":"Ali, S. et al. Patterns, outcomes and trends in hospital visits of un-operated and operated children with rheumatic heart disease in Sudan. Cardiovasc. Diagn. Ther. 9, 165 (2019).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"685_CR139","doi-asserted-by":"publisher","DOI":"10.1136\/heartasia-2019-011191","volume":"11","author":"S Marantelli","year":"2019","unstructured":"Marantelli, S., Hand, R., Carapetis, J., Beaton, A. & Wyber, R. Severe adverse events following benzathine penicillin G injection for rheumatic heart disease prophylaxis: cardiac compromise more likely than anaphylaxis. Heart Asia 11, e011191 (2019).","journal-title":"Heart Asia"},{"key":"685_CR140","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024517","volume":"11","author":"A Sanyahumbi","year":"2022","unstructured":"Sanyahumbi, A. et al. Penicillin reactions in patients with severe rheumatic heart disease: a Presidential Advisory from the American Heart Association. J. Am. Heart Assoc. 11, e024517 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"685_CR141","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5694\/mja2.50851","volume":"214","author":"AP Ralph","year":"2021","unstructured":"Ralph, A. P., Noonan, S., Wade, V. & Currie, B. J. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Med. J. Aust. 214, 220\u2013227 (2021).","journal-title":"Med. J. Aust."},{"key":"685_CR142","doi-asserted-by":"publisher","first-page":"e707","DOI":"10.1016\/S2214-109X(24)00527-8","volume":"13","author":"S de Loizaga","year":"2025","unstructured":"de Loizaga, S. et al. Enhanced support for adherence to rheumatic heart disease prophylaxis for children in the public health system in Uganda (CAMPS): a pragmatic randomised trial. Lancet Glob. Health 13, e707\u2013e715 (2025).","journal-title":"Lancet Glob. Health"},{"key":"685_CR143","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00962-23","volume":"67","author":"J Kado","year":"2023","unstructured":"Kado, J. et al. Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study. Antimicrob. Agents Chemother. 67, e0096223 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"685_CR144","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/S0140-6736(25)00185-0","volume":"405","author":"K Hirani","year":"2025","unstructured":"Hirani, K. et al. Acute rheumatic fever. Lancet 405, 2164\u20132178 (2025).","journal-title":"Lancet"},{"key":"685_CR145","volume":"6","author":"A Cilliers","year":"2012","unstructured":"Cilliers, A., Manyemba, J., Adler, A. J. & Saloojee, H. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst. Rev. 6, CD003176 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"685_CR146","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06259006 (2025)."},{"key":"685_CR147","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijcard.2022.05.053","volume":"362","author":"F Perelini","year":"2022","unstructured":"Perelini, F. et al. Revisiting QT prolongation in acute rheumatic fever - relevance for hydroxychloroquine treatment. Int. J. Cardiol. 362, 93\u201396 (2022).","journal-title":"Int. J. Cardiol."},{"key":"685_CR148","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamacardio.2020.7050","volume":"6","author":"P Karki","year":"2021","unstructured":"Karki, P. et al. Effectiveness of systematic echocardiographic screening for rheumatic heart disease in Nepalese schoolchildren: a cluster randomized clinical trial. JAMA Cardiol. 6, 420\u2013426 (2021).","journal-title":"JAMA Cardiol."},{"key":"685_CR149","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jacc.2023.05.061","volume":"82","author":"A Coisne","year":"2023","unstructured":"Coisne, A. et al. ACC\/AHA and ESC\/EACTS guidelines for the management of valvular heart diseases: JACC guideline comparison. J. Am. Coll. Cardiol. 82, 721\u2013734 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"685_CR150","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.2147\/IJGM.S419118","volume":"16","author":"M Nasir","year":"2023","unstructured":"Nasir, M. et al. Health related quality of life and associated factors among adult patients with rheumatic heart disease patients in Ethiopia. Int. J. Gen. Med. 16, 3403\u20133412 (2023).","journal-title":"Int. J. Gen. Med."},{"key":"685_CR151","unstructured":"Okello, E. M. et al. in Acute Rheumatic Fever and Rheumatic Heart Disease (eds Dougherty, S., Carapetis, J., Z\u00fchlke, L. & Wilson, N.) Ch. 6 (Elsevier, 2020)."},{"key":"685_CR152","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1056\/NEJMoa2209051","volume":"387","author":"SJ Connolly","year":"2022","unstructured":"Connolly, S. J. et al. Rivaroxaban in rheumatic heart disease-associated atrial fibrillation. N. Engl. J. Med. 387, 978\u2013988 (2022).","journal-title":"N. Engl. J. Med."},{"key":"685_CR153","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/hrt.60.4.299","volume":"60","author":"GT Wilkins","year":"1988","unstructured":"Wilkins, G. T., Weyman, A. E., Abascal, V. M., Block, P. C. & Palacios, I. F. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br. Heart J. 60, 299\u2013308 (1988).","journal-title":"Br. Heart J."},{"key":"685_CR154","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","volume":"77","author":"CM Otto","year":"2021","unstructured":"Otto, C. M. et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary. JACC 77, 450\u2013500 (2021).","journal-title":"JACC"},{"key":"685_CR155","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2021","unstructured":"Vahanian, A. et al. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 43, 561\u2013632 (2021).","journal-title":"Eur. Heart J."},{"key":"685_CR156","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012031","volume":"8","author":"C Desnos","year":"2019","unstructured":"Desnos, C. et al. Temporal trends on percutaneous mitral commissurotomy: 30 years of experience. J. Am. Heart Assoc. 8, e012031 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"685_CR157","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ijcard.2014.10.040","volume":"177","author":"F Tomai","year":"2014","unstructured":"Tomai, F. et al. Twenty year follow-up after successful percutaneous balloon mitral valvuloplasty in a large contemporary series of patients with mitral stenosis. Int. J. Cardiol. 177, 881\u2013885 (2014).","journal-title":"Int. J. Cardiol."},{"key":"685_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-016-0451-8","volume":"17","author":"E Okello","year":"2017","unstructured":"Okello, E., Longenecker, C. T., Beaton, A., Kamya, M. R. & Lwabi, P. Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation. BMC Cardiovasc. Disord. 17, 20 (2017).","journal-title":"BMC Cardiovasc. Disord."},{"key":"685_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102530","volume":"49","author":"F Yasmin","year":"2024","unstructured":"Yasmin, F. et al. Comparative efficacy and safety of mitral valve repair versus mitral valve replacement in improving clinical outcomes in patients with rhematic heart disease: a high-value care systematic review and meta-analysis. Curr. Probl. Cardiol. 49, 102530 (2024).","journal-title":"Curr. Probl. Cardiol."},{"key":"685_CR160","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jtcvs.2021.03.033","volume":"165","author":"C-Y Chen","year":"2023","unstructured":"Chen, C.-Y. et al. Bioprosthetic versus mechanical mitral valve replacements in patients with rheumatic heart disease. J. Thorac. Cardiovasc. Surg. 165, 1050\u20131060. e1058 (2023).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"685_CR161","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.acvd.2015.12.004","volume":"109","author":"S Kingu\u00e9","year":"2016","unstructured":"Kingu\u00e9, S. et al. The VALVAFRIC study: a registry of rheumatic heart disease in Western and Central Africa. Arch. Cardiovasc. Dis. 109, 321\u2013329 (2016).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"685_CR162","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","volume":"39","author":"V Regitz-Zagrosek","year":"2018","unstructured":"Regitz-Zagrosek, V. et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur. Heart J. 39, 3165\u20133241 (2018).","journal-title":"Eur. Heart J."},{"key":"685_CR163","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ihj.2021.01.012","volume":"73","author":"R Khanna","year":"2021","unstructured":"Khanna, R. et al. Maternal and fetal outcomes in pregnant females with rheumatic heart disease. Indian Heart J. 73, 185\u2013189 (2021).","journal-title":"Indian Heart J."},{"key":"685_CR164","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1258\/om.2010.100067","volume":"4","author":"P Soma-Pillay","year":"2011","unstructured":"Soma-Pillay, P., Nene, Z., Mathivha, T. M. & Macdonald, A. P. The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves. Obstet. Med. 4, 24\u201327 (2011).","journal-title":"Obstet. Med."},{"key":"685_CR165","doi-asserted-by":"publisher","DOI":"10.15420\/icr.2020.06","volume":"15","author":"C Fraccaro","year":"2020","unstructured":"Fraccaro, C., Tence, N., Masiero, G. & Karam, N. Management of valvular disease during pregnancy: evolving role of percutaneous treatment. Interv. Cardiol. 15, e10 (2020).","journal-title":"Interv. Cardiol."},{"key":"685_CR166","first-page":"2045","volume":"37","author":"B Cupido","year":"2021","unstructured":"Cupido, B., Z\u00fchlke, L., Osman, A., van Dyk, D. & Sliwa, K. Managing rheumatic heart disease in pregnancy: a practical evidence-based multidisciplinary approach. Can. J. Cardiol. 37, 2045\u20132055 (2021).","journal-title":"Can. J. Cardiol."},{"key":"685_CR167","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12872-024-04092-7","volume":"24","author":"A Mengie","year":"2024","unstructured":"Mengie, A. et al. Prevalence and associated factors of atrial fibrillation among patients with rheumatic heart disease attending public referral hospitals in Bahir Dar city, Northwest Ethiopia, 2023. BMC Cardiovasc. Disord. 24, 434 (2024).","journal-title":"BMC Cardiovasc. Disord."},{"key":"685_CR168","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.hroo.2022.09.020","volume":"3","author":"J Shenthar","year":"2022","unstructured":"Shenthar, J. Management of atrial fibrillation in rheumatic heart disease. Heart Rhythm. O2 3, 752\u2013759 (2022).","journal-title":"Heart Rhythm. O2"},{"key":"685_CR169","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11936-020-00845-7","volume":"22","author":"A Bansal","year":"2020","unstructured":"Bansal, A., Sarkar, P. G. & Chaturvedi, V. Atrial fibrillation in rheumatic heart disease. Curr. Treat. Options Cardiovasc. Med. 22, 42 (2020).","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"685_CR170","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/ehjqcco\/qcae106","volume":"11","author":"MA Borger","year":"2025","unstructured":"Borger, M. A. et al. Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings. Eur. Heart J. Qual. Care Clin. Outcomes 11, 691\u2013697 (2025).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"685_CR171","first-page":"62","volume":"135","author":"A Alsamarrai","year":"2022","unstructured":"Alsamarrai, A. et al. Infective endocarditis in patients with rheumatic heart disease: a single-centre retrospective comparative study. N. Z. Med. J. 135, 62\u201373 (2022).","journal-title":"N. Z. Med. J."},{"key":"685_CR172","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5334\/gh.1205","volume":"18","author":"MAM Ahmed","year":"2023","unstructured":"Ahmed, M. A. M. et al. Health related quality of life of Ugandan children following valve replacement surgery for rheumatic heart disease. Glob. Heart 18, 37 (2023).","journal-title":"Glob. Heart"},{"key":"685_CR173","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12872-023-03504-4","volume":"23","author":"PP Shimanda","year":"2023","unstructured":"Shimanda, P. P. et al. Health-related quality of life and healthcare consultations among adult patients before and after diagnosis with rheumatic heart disease in Namibia. BMC Cardiovasc. Disord. 23, 456 (2023).","journal-title":"BMC Cardiovasc. Disord."},{"key":"685_CR174","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/heartasia-2014-010562","volume":"6","author":"LJ Thomson Mangnall","year":"2014","unstructured":"Thomson Mangnall, L. J., Sibbritt, D. W., Fry, M., Windus, M. & Gallagher, R. D. Health-related quality of life of patients after mechanical valve replacement surgery for rheumatic heart disease in a developing country. Heart Asia 6, 172\u2013178 (2014).","journal-title":"Heart Asia"},{"key":"685_CR175","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259340","volume":"16","author":"J Dixit","year":"2021","unstructured":"Dixit, J., Jyani, G., Prinja, S. & Sharma, Y. Health related quality of life among rheumatic fever and rheumatic heart disease patients in India. PLoS ONE 16, e0259340 (2021).","journal-title":"PLoS ONE"},{"key":"685_CR176","first-page":"370","volume":"68","author":"A Riaz","year":"2018","unstructured":"Riaz, A. et al. Quality of life in patients with rheumatic heart disease. J. Pak. Med. Assoc. 68, 370\u2013375 (2018).","journal-title":"J. Pak. Med. Assoc."},{"key":"685_CR177","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5334\/gh.1181","volume":"18","author":"H Nalubwama","year":"2023","unstructured":"Nalubwama, H. et al. A qualitative study of patients\u2019 experiences, enablers and barriers of rheumatic heart disease care in Uganda. Glob. Heart 18, 6 (2023).","journal-title":"Glob. Heart"},{"key":"685_CR178","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jpeds.2016.04.087","volume":"175","author":"T Bradley-Hewitt","year":"2016","unstructured":"Bradley-Hewitt, T. et al. The impact of echocardiographic screening for rheumatic heart disease on patient quality of life. J. Pediatr. 175, 123\u2013129 (2016).","journal-title":"J. Pediatr."},{"key":"685_CR179","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1590\/1984-0462\/;2018;36;2;00012","volume":"36","author":"ALS Melo","year":"2018","unstructured":"Melo, A. L. S. et al. Exercise tolerance, pulmonary function, respiratory muscle strength, and quality of life in children and adolescents with rheumatic heart disease. Rev. Paul. Pediatr. 36, 199\u2013206 (2018).","journal-title":"Rev. Paul. Pediatr."},{"key":"685_CR180","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrcardio.2012.197","volume":"10","author":"R Tandon","year":"2013","unstructured":"Tandon, R. et al. Revisiting the pathogenesis of rheumatic fever and carditis. Nat. Rev. Cardiol. 10, 171\u2013177 (2013).","journal-title":"Nat. Rev. Cardiol."},{"key":"685_CR181","first-page":"643","volume":"137","author":"RK Kumar","year":"2013","unstructured":"Kumar, R. K. & Tandon, R. Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J. Med. Res. 137, 643\u2013658 (2013).","journal-title":"Indian J. Med. Res."},{"key":"685_CR182","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012355","volume":"8","author":"D Vervoort","year":"2023","unstructured":"Vervoort, D. et al. Tertiary prevention and treatment of rheumatic heart disease: a National Heart, Lung, and Blood Institute working group summary. BMJ Glob. Health 8, e012355 (2023).","journal-title":"BMJ Glob. Health"},{"key":"685_CR183","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012468","volume":"8","author":"G Karthikeyan","year":"2023","unstructured":"Karthikeyan, G. et al. Research priorities for the secondary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood institute workshop report. BMJ Glob. Health 8, e012468 (2023).","journal-title":"BMJ Glob. Health"},{"key":"685_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101347","volume":"3","author":"IA Aliyu","year":"2024","unstructured":"Aliyu, I. A. et al. Rheumatic heart disease burden in africa and the need to build robust infrastructure. JACC Adv. 3, 101347 (2024).","journal-title":"JACC Adv."},{"key":"685_CR185","first-page":"206","volume":"29","author":"MCP Ntsekhe","year":"2018","unstructured":"Ntsekhe, M. C. P., Brink, P. & Yusuf, S. Bongani Mayosi, a hero remembered. Cardiovasc. J. Afr. 29, 206 (2018).","journal-title":"Cardiovasc. J. Afr."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00685-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00685-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00685-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:02:46Z","timestamp":1789142566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00685-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":185,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1038\/s41572-026-00685-y","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"26 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, in Table 1, the column headings \u201cLow risk\u201d and \u201cModerate and high risk\u201d were switched and have now been amended. Additionally, the yellow arrows in Fig. 7Ea had shifted upwards and have now been corrected. These corrections have been made to the HTML and PDF versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.Z. has research supported by the Division of Research Capacity Development, Foreign Commonwealth and Development Office, UK, National Research Foundation of South Africa, South African Medical Research Council, (grant number Mid-Career Scientist Program, MR\/S005242\/1), Gates Foundation, British Heart Foundation through the University of Manchester,\u00a0The Leducq Foundation and Coeffiecient Giving. She is also a member of RHD Vaccine Advisory Committee of the Leducq Foundation. A.B. has research supported by the NIH, Thrasher Research Foundation, The Leducq Foundation, The American Heart Association and Open Philanthropy. She also receives programmatic support from Edwards Lifesciences Foundation, The Philips Foundation and Huron Philanthropies. R.K.K. is a member of RHD Heart Valve Advisory Committee of the LeDucq Foundation. N.J.M. is an inventor on a patent related to streptococcal serology. D.W. reports funding from the NIH (1R01HL164615) for rheumatic heart disease research. C.Y. is partially supported by the NIH under award numbers U01AI151801 and D43TW012246. The funding body, however, had no role in the design of the study and collection, analysis and interpretation of data, and in writing the manuscript. J.C. is supported by an Investigator Grant from the National Health and Medical Research Council of Australia.\u00a0All\u00a0other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7"}}